Top FDA official interested in ‘Project Orbis’ for cell and gene therapies
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsComplianceNorth AmericaQuality Assurance and ControlRegulatory Intelligence/Policy